#nephJC
A new #NephJC 🩳 by @nephromommy-akshu.bsky.social
Can dobutamine and Norepinephrine keep the kidneys out of a septic storm ⛈️? #NephSky
www.nephjc.com/news/intraopdobutamineshort
Inotrope in the OR: does dobutamine (+Norepi) keep the kidneys out of the septic storm? — NephJC
Does dobutamine reduce AKI risk ruring surgery for septic shock?
www.nephjc.com
November 21, 2026 at 10:25 PM
Can a video help older patients decide between HD, PD, and conservative care, and get that decision into the chart?

🎨 #NephjC visual abstract by @assadsm.bsky.social

www.nephjc.com/news/thevide...
The Video KD: The Visual Abstract — NephJC
Can a video decision aid improve older adults with advanced CKD make treatment decisions?
www.nephjc.com
November 17, 2026 at 2:51 PM
¿Puede un video ayudar a los pacientes mayores a decidir entre HD, DP y tratamiento conservador, y lograr que esa decisión quede registrada en la historia clínica? #NephJC

🎨 #ResumenVisual de VIDEO-KD por @assadsm.bsky.social , traducir por @dramiliflores.bsky.social
www.nephjc.com/news/elvideokd
El Video KD: El Resumen Visual — NephJC
¿Puede un video ayudar a los adultos mayores con ERCA a tomar decisiones terapéuticas?
www.nephjc.com
November 17, 2026 at 2:53 PM
1/10
#NephJC #TenPostNephJC.
#NephSky
Video Decision Support and Advance Care Planning in Older Adults with Advanced Kidney Disease

Can a video decision aid help patients with dialysis decisions?
Read the article 👇 VIDEO KD
jamanetwork.com/journals/jam...
November 18, 2026 at 2:23 AM
Half of older adults with advanced CKD said they’d prefer conservative care after a 12-min video #nephjc

A year later, charts told a different story

✍️ @ancast13.bsky.social @kiddokidney.bsky.social

VIDEO-KD, @jamainternalmed.com, and what got lost in transmission
www.nephjc.com/news/videokd
Motivational Videos and Dialysis Decisions — NephJC
This week, we will discuss use of video aids to help with advanced care planning for dialysis and conservative kidney care in the elderly.
www.nephjc.com
November 17, 2026 at 2:45 PM
8/10
#NephJC Consensus:
Video decision support & patient authored ViDECs ⬆️ Advance Care Planning documentation & ⬇️ treatment indecision.
Educating patients about conservative management does not ⬇️ HD interest
Real world uptake & goal concordant outcomes still need testing
November 18, 2026 at 2:23 AM
7/10
Question 2
#NephJC #NephSky
Does EHR documentation mean better ESKD care?
Not proven yet! Advance Care Planning improved documentation, knowledge & decisional certainty. However, longer F/U is needed to see if clinicians honor preferences when dialysis becomes urgent.
November 18, 2026 at 2:23 AM
6/10
Question 1
#NephJC #NephSky
Should we use video decision aids/ViDEC for all adults with advanced CKD?
Feasible: 91% completed a ViDEC & 89% were comfortable watching. Still, trained nurses/social workers delivered it, at mostly academic clinics & generalizability matters.
November 18, 2026 at 2:23 AM
PLEX or daratumumab for myeloma cast nephropathy? A 549-patient target trial emulation found neither linked to better kidney recovery at 90 days. Glimmer of hope or mirage?
⬇️New #NephJC Short by @brianrifkin.bsky.social
www.nephjc.com/news/daravsp...
Can Daratumumab or PLEX Improve Renal Outcomes in Myeloma Cast Nephropathy? — NephJC
In myeloma cast nephropathy does daratumumab or plasma exchange change renal outcomes?
www.nephjc.com
November 9, 2026 at 2:03 PM
Those are extremely impressive blood pressure reductions for a drug designed for weight loss! Up to 15mmHg ⬇️ for stage 2 hypertension in obesity(Attain-1) or diabetes(Attain-2)

#NephJC

The phase 3 hypertension trials also includes detailed renal substudy to figure out the mechanism at play here.
November 5, 2026 at 5:50 PM
1/10 #NephJC #TenPosts
🫘 Intermittent HD or continuous RRT for critically ill patients with AKI?
⚖️ For years, trials suggested similar outcomes. Does the choice of modality affect survival?
💥 The ICRAKI trial challenges previous evidence
www.nejm.org/doi/10.1056/... #NephJC #TenPosts
November 4, 2026 at 1:53 AM
ICRAKI- intermittent vs continuous RRT in patients with AKI in the ICU.
VA by @farahwehbe92.bsky.social
#NephSky #NephJC
www.nephjc.com/news/icraki-the-visual-abstract
ICRAKI: The Visual Abstract — NephJC
Intermittent or continuous RRT for severe AKI: Does the Choice Matter?
www.nephjc.com
November 2, 2026 at 8:57 PM
11/10 #NephJC Poll
In your ICU, which RRT modality is most commonly used for hemodynamically unstable patients with AKI?
🔘 CRRT
🔘 SLED
🔘 IHD
💬 Does the ICRAKI trial make you reconsider your current practice?
November 4, 2026 at 1:53 AM
ICRAKI challenges our approach to KRT in severe AKI: IHD did not meet noninferiority for MAKE90; a mortality signal favored CRRT, but early stopping limits inference. The IHD prescription matters. Excellent critical appraisal by #NephJC.

www.nephjc.com/news/icraki1...
ICRAKI-ng the code on RRT — NephJC
This week, we will discuss intermittent hemodialysis versus continuous hemodialysis for AKI in the ICU (ICRAKI study)
www.nephjc.com
November 4, 2026 at 3:33 AM
9/10 I want more info
📖 Read the full ICRAKI trial:
Gaudry S et al. Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury.
NEJM, 2026.
🔗 DOI: 10.1056/NEJMoa2608397
🫘 Check out the #NephJC discussion! @DivyaveerSSNeph @rn_flex
www.nephjc.com/news/icraki1...
ICRAKI-ng the code on RRT — NephJC
This week, we will discuss intermittent hemodialysis versus continuous hemodialysis for AKI in the ICU (ICRAKI study)
www.nephjc.com
November 4, 2026 at 1:53 AM
IHD vs CRRT again. ICRAKI was stopped early due to higher mortality with IHD. Real signal or truncation artifact? And was IHD given the way we'd give it to a patient on vasopressors? #NephJC #nephsky

✍️ @rnflex.bsky.social @divyaveerssneph.bsky.social
www.nephjc.com/news/icraki1...
ICRAKI-ng the code on RRT — NephJC
This week, we will discuss intermittent hemodialysis versus continuous hemodialysis for AKI in the ICU (ICRAKI study)
www.nephjc.com
November 2, 2026 at 3:21 PM
8/10 ⚠️ #NephJC Consensus
💡 Strengths: randomized, multicenter, contemporary trial with clear RRT indications
⚠️ Limitations: early termination, open-label design, treatment crossover and slightly subtarget IHD dose
🫘 Kidney-specific outcomes remain uncertain
November 4, 2026 at 1:53 AM
7/10 Question 2
#NephJC #NephSky
❓ Could hemodynamic instability explain the mortality difference?
💉 Post hoc analyses suggested greater catecholamine requirements with IHD
⚠️ But no clear treatment-effect heterogeneity was observed by baseline catecholamine support
November 4, 2026 at 1:53 AM
Forget afterparties. The coolest #KidneyWk gathering is still #NephJC

Being there for a live @FreelyFiltered recording was a whole different vibe. Be honest... which LBCT already has a half-written draft sitting in your notes?

@nephjc.bsky.social @kidneyboy.bsky.social @brianrifkin.bsky.social
November 3, 2026 at 1:25 AM
6/10 Question 1
#NephJC #NephSky
❓ Should CRRT now become the preferred initial modality for all critically ill patients with severe AKI?
💭 ICRAKI raises an important question: is intermittent HD as safe as we previously assumed?
November 4, 2026 at 1:53 AM
IHD vs CRRT in AKI: Does the choice of modality really impact survival? 🫘 #NephJC
November 2, 2026 at 3:43 PM
We wrote about the US data here on #NephJC www.nephjc.com/news/2025/7/...
NephJC Shorts: Should we Screen for Kidney Disease? — NephJC
Should we screen for CKD?
www.nephjc.com
October 26, 2026 at 12:03 AM
With the plethora of riches in IgA nephropathy therapeutics - we had some fun making this comparative table

See more caveats here www.nephjc.com/news/2026/10...

#KidneyWk #NephJC
October 25, 2026 at 5:39 PM